Skip to main content

Testosterone Dosage

Medically reviewed by Drugs.com. Last updated on Oct 15, 2024.

Applies to the following strengths: 30 mg/actuation; 2.5 mg/24 hr; 5 mg/24 hr; cypionate 100 mg/mL; cypionate 200 mg/mL; 2 mg/24 hr; 4 mg/24 hr; 25 mg/2.5 g (1%); 50 mg/5 g (1%); 40.5 mg/2.5 g (1.62%); 20.25 mg/1.25 g (1.62%); 20.25 mg/actuation (1.62%); 12.5 mg/1.25 g (1%); enanthate 200 mg/mL; 100 mg/mL; propionate 100 mg/mL; enanthate 100 mg/mL; 50 mg/mL; micronized; propionate; 10 mg/0.5 g; 75 mg; 6 mg/24 hr; propionate micronized; cypionate; 5.5 mg/0.122 g; 30 mg/12 hr; undecanoate 112.5 mg; enanthate 100 mg/0.5 mL; enanthate 50 mg/0.5 mL; enanthate 75 mg/0.5 mL; 2%; undecanoate 250 mg/mL; 158 mg; 198 mg; 237 mg; 100 mg; 150 mg; 200 mg

Usual Adult Dose for Hypogonadism - Male

IM INJECTION:


IMPLANT:

Comments:

BUCCAL:

TOPICAL:

Comments: Prior to initiating therapy with this drug, confirm the diagnosis of hypogonadism by ensuring that serum testosterone concentrations have been measured in the morning on at least two separate days, and that these serum testosterone concentrations are below the normal range.

Uses:

Usual Adult Dose for Breast Cancer-Palliative

Testosterone Enanthate:


Comments:

Uses:

Usual Pediatric Dose for Delayed Puberty - Male

IM INJECTION:


IMPLANT:

Comments:

Use: To stimulate puberty in selected males with clearly delayed puberty

Renal Dose Adjustments

Testosterone Cypionate IM injection: Contraindicated in renal disease

Liver Dose Adjustments

Testosterone Cypionate IM injection: Contraindicated in liver disease

Dose Adjustments

The doses of this drug should be adjusted according to the patient's response and the appearance of adverse reactions.

IMPLANTS:
The number of pellets to be implanted depends upon the minimal daily requirements of testosterone propionate determined by a gradual reduction of the amount administered parenterally. The usual dosage is as follows:


TOPICAL:

Precautions

The US FDA requires a Risk Evaluation and Mitigation Strategy (REMS) medication guide for Testosterone. For Testosterone Undecanoate, REMS includes elements to assure safe use and implementation system . For additional information: www.fda.gov/REMS

US BOXED WARNINGS:
Pulmonary Oil Microembolism (POME) Reactions And Anaphylaxis:


Secondary Exposure To Topical Testosterone:

Safety and efficacy have not been established in patients younger than 18 years.

Testosterone Enanthate and Testosterone Implant are indicated for delayed puberty in adolescent patients.

Testosterone Cypionate: Safety and efficacy have not been established in patients younger than 12 years.

Consult WARNINGS section for additional precautions.

Dialysis

Data not available

Other Comments

Administration advice:
Mucoadhesive Oral Patch:


IM Injection:

Topical:

General:

Limitations of use:

Monitoring:

Patient advice:

Frequently asked questions

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.